Literature DB >> 2707859

Antilipopolysaccharide factor from horseshoe crab, Tachypleus tridentatus, inhibits lipopolysaccharide activation of cultured human endothelial cells.

C E Desch1, P O'Hara, J M Harlan.   

Abstract

Antilipopolysaccharide (anti-LPS) factor is a basic protein that is purified from the hemocyte lysate of the Japanese and American horseshoe crabs (Tachypleus tridentatus and Limulus polyphemus). Anti-LPS factor has previously been reported to inhibit LPS-mediated activation of limulus factor C, lyse endotoxin-sensitized erythrocytes, and inhibit the growth of some gram-negative bacteria. In this study, we examine the ability of anti-LPS factor purified from T. tridentatus to inhibit the activation of cultured human endothelial cells by LPS. Anti-LPS factor inhibited the stimulation of endothelial adhesiveness for neutrophils by LPS in a dose-dependent manner. Maximum inhibition was achieved when anti-LPS factor was mixed with LPS prior to addition to the endothelial cell monolayers. Anti-LPS factor inhibited endothelial cell activation by LPS derived from Salmonella minnesota Re and Rc mutants as well as from the wild type (smooth), suggesting that it recognizes the lipid A moiety of LPS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707859      PMCID: PMC313321          DOI: 10.1128/iai.57.5.1612-1614.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamine.

Authors:  M Hanss; D Collen
Journal:  J Lab Clin Med       Date:  1987-01

2.  Primary structure of limulus anticoagulant anti-lipopolysaccharide factor.

Authors:  J Aketagawa; T Miyata; S Ohtsubo; T Nakamura; T Morita; H Hayashida; T Miyata; S Iwanaga; T Takao; Y Shimonishi
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

3.  American Association of Pathologists president's address. New roles for the endothelium in inflammation and immunity.

Authors:  R S Cotran
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

Review 4.  Inducible endothelial functions in inflammation and coagulation.

Authors:  M P Bevilacqua; M A Gimbrone
Journal:  Semin Thromb Hemost       Date:  1987-10       Impact factor: 4.180

5.  Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells.

Authors:  P Libby; J M Ordovas; K R Auger; A H Robbins; L K Birinyi; C A Dinarello
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

6.  Cultured human vascular endothelial cells acquire adhesiveness for neutrophils after stimulation with interleukin 1, endotoxin, and tumor-promoting phorbol diesters.

Authors:  R P Schleimer; B K Rutledge
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

7.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus.

Authors:  T Muta; T Miyata; F Tokunaga; T Nakamura; S Iwanaga
Journal:  J Biochem       Date:  1987-06       Impact factor: 3.387

9.  Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells.

Authors:  J J Emeis; T Kooistra
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

10.  Deacylated lipopolysaccharide inhibits neutrophil adherence to endothelium induced by lipopolysaccharide in vitro.

Authors:  T H Pohlman; R S Munford; J M Harlan
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more
  7 in total

1.  Endotoxin-neutralizing protein protects against endotoxin-induced endothelial barrier dysfunction.

Authors:  D D Bannerman; M J Fitzpatrick; D Y Anderson; A K Bhattacharjee; T J Novitsky; J D Hasday; A S Cross; S E Goldblum
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

2.  Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor.

Authors:  H S Warren; M L Glennon; N Wainwright; S F Amato; K M Black; S J Kirsch; G R Riveau; R I Whyte; W M Zapol; T J Novitsky
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  Pulmonary Endothelial Cell Apoptosis in Emphysema and Acute Lung Injury.

Authors:  Eboni Chambers; Sharon Rounds; Qing Lu
Journal:  Adv Anat Embryol Cell Biol       Date:  2018       Impact factor: 1.231

4.  Cloning of anti-lPS factor cDNA from Tachypleus tridentatus, expression in Bombyx mori larvae and its biological activity in vitro.

Authors:  Dong-Ning Wang; Jie-Wu Liu; Guan-Zhen Yang; Wei-Jie Zhang; Xiang-Fu Wu
Journal:  Mol Biotechnol       Date:  2002-05       Impact factor: 2.695

5.  Binding between lipopolysaccharide and cecropin A.

Authors:  A J De Lucca; T J Jacks; K A Brogden
Journal:  Mol Cell Biochem       Date:  1995-10-18       Impact factor: 3.396

Review 6.  The role of biophysical parameters in the antilipopolysaccharide activities of antimicrobial peptides from marine fish.

Authors:  Ramamourthy Gopal; Chang Ho Seo; Yoonkyung Park
Journal:  Mar Drugs       Date:  2014-03-13       Impact factor: 5.118

7.  Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution.

Authors:  A Hoess; S Watson; G R Siber; R Liddington
Journal:  EMBO J       Date:  1993-09       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.